参考文献/References:
[1] Ramakrishnan VR, Suh JD, Lee JY, et al. Sphenoid sinus
anatomy and suprasellar extension of pituitary tumors [J]. J
Neurosurg, 2013, 119(3): 669-674.
[2] Thomas R, Shenoy K, Seshadri MS, et al. Visual field defects
in non-functioning pituitary adenomas [J]. Indian J
Ophthalmol, 2002, 50: 127-130.
[3] Carrim ZI, Reeks GA, Chohan AW, et al. Predicting impair-
ment of central vision from dimensions of the optic chiasm
in patients with pituitary adenoma [J]. Acta Neurochir
(Wien), 2007, 149(3): 255-260.
[4] Jaeger W, Thomann H, German Ophthalmological Associa-
tion. Recommendations for evaluation of reduced earning
capacity caused by damage to vision [J]. Klin Monbl
Augenheilkd, 1982, 180: 242-244.
[5] Müslüman AM, Cansever T, Y?lmaz A, et al. Surgical results
of large and giant pituitary adenomas with special conside-
ration of ophthalmologic outcomes [J]. World Neurosurg,
2011, 76: 141-148.
[6] Garibi J, Pomposo I, Villar G, et al. Giant pituitary adeno-
mas: clinical characteristics and surgical results [J]. Br J
Neurosurg, 2002, 16: 133-139.
[7] Goel A, Nadkarni T, Muzumdar D, et al. Giant pituitary
tumors: a study based on surgical treatment of 118 cases [J].
Surg Neurol, 2004, 61: 436-445.
[8] Ebersold MJ, Quast LM, Laws ER Jr, et al. Long-term
results in transsphenoidal removal of nonfunctioning pitui-
tary adenomas [J]. J Neurosurg, 1986, 64: 713-719.
[9] Monteiro ML, Zambon BK, Cunha LP. Predictive factors for
the development of visual loss in patients with pituitary
macroadenomas and for visual recovery after optic pathway
decompression [J]. Can J Ophthalmol, 2010, 45: 404-408.
[10] Ho RW, Huang HM, Ho JT. The influence of pituitary
adenoma size on vision and visual outcomes after trans-
sphenoidal adenectomy: a report of 78 cases [J]. J Korean
Neurosurg Soc, 2015, 57(1): 23-31.
[11] Levy A. Pituitary disease:presentation, diagnosis, and mana-
gement [J]. J Neurol Neurosurg Psychiatry, 2004, 75 (Suppl
3): iii47-52.
[12] Rivoal O, Brézin AP, Feldman-Billard S, et al. Goldmann
perimetry in acromegaly: a survey of 307 cases from 1951
through 1996 [J]. Ophthalmology, 2000, 107: 991-997.
[13] Lee JP, Park IW, Chung YS. The volume of tumor mass and
visual field defect in patients with pituitary macroadenoma
[J]. Korean J Ophthalmol, 2011, 25: 37-41.
[14] Chang EF, Zada G, Kim S, et al. Long-term recurrence and
mortality after surgery and adjuvant radiotherapy for non-
functional pituitary adenomas [J]. J Neurosurg, 2008, 108:
736-745.
[15] Roelfsema F, Biermasz NR, Pereira AM. Clinical factors
involved in the recurrence of pituitary adenomas after
surgical remission: a structured review and meta-analysis
[J]. Pituitary, 2012, 15: 71-83.
[16] Ikeda H, Yoshimoto T. Visual disturbances in patients with
pituitary adenoma [J]. Acta Neurol Scand, 1995, 92: 157-
160.
相似文献/References:
[1]余龙洋 李亚楠 周 宇 戴冬伟 曹依群 岳志健.垂体腺瘤经蝶术后并发蛛网膜下腔出血的临床分析
(附6例报道)[J].中国临床神经外科杂志,2016,(06):372.[doi:10.13798/j.issn.1009-153X.2016.06.018]
[2]王国良 高 寒 张小鹏 公方和 李天栋.89例垂体腺瘤的手术治疗体会[J].中国临床神经外科杂志,2016,(07):435.[doi:10.13798/j.issn.1009-153X.2016.07.016]
[3]王亚平 贾晓雄 王 珺 王林林 谭溢涛 马德得 夏鹤春.神经内镜下与显微镜下经鼻蝶入路手术切除垂体腺瘤的疗效对比分析[J].中国临床神经外科杂志,2016,(03):145.[doi:10.13798/j.issn.1009-153X.2016.03.004]
WANG Ya-ping,JIA Xiao-xiong,WANG-Jun,et al.Resection of pituitary adenomas by endoscopic and microscopic surgery via transnasal transsphenoidal approach: a comparative analysis[J].,2016,(01):145.[doi:10.13798/j.issn.1009-153X.2016.03.004]
[4]王先祥 张义泉 李庆新 王 斌 肖 瑾 张 科.经单鼻孔蝶窦入路神经内镜下切除垂体腺瘤[J].中国临床神经外科杂志,2015,(12):715.[doi:10.13798/j.issn.1009-153X.2015.12.004]
WANG Xian-xiang,ZHANG Yi-quan,LI Qing-xin,et al.Endoscopic endonasal transsphenoidal surgery for pituitary adenomas[J].,2015,(01):715.[doi:10.13798/j.issn.1009-153X.2015.12.004]
[5]马 涛 徐 韬.经蝶入路内镜手术与显微手术治疗垂体腺瘤疗效的Meta分析[J].中国临床神经外科杂志,2015,(12):748.[doi:10.13798/j.issn.1009-153X.2015.12.015]
[6]雷 霆.注重基础训练和知识更新,不断提高垂体腺瘤诊疗水平[J].中国临床神经外科杂志,2015,(10):577.[doi:10.13798/j.issn.1009-153X.2015.10.001]
[7]闫 进 李 松 杨 辉.1H-MRS对卵泡刺激素免疫阳性垂体腺瘤的诊断和预后评估的价值[J].中国临床神经外科杂志,2015,(10):588.[doi:10.13798/j.issn.1009-153X.2015.10.004]
YAN Jin,LI Song,YANG Hui..Value of 1H-MRS to diagnosis and assessment of prognoses in patients with non-functioning gonadotroph adenomas[J].,2015,(01):588.[doi:10.13798/j.issn.1009-153X.2015.10.004]
[8]夏为民 邵耐远 唐 科.神经内镜辅助经鼻蝶入路手术治疗急性垂体腺瘤卒中[J].中国临床神经外科杂志,2015,(07):437.[doi:10.13798/j.issn.1009-153X.2015.07.020]
[9]王齐齐 陈 俊 王焕明 胡 飞.脊索瘤合并垂体腺瘤1例[J].中国临床神经外科杂志,2015,(07):448.[doi:10.13798/j.issn.1009-153X.2015.07.025]
[10]秦 汉 胡军民 秦海林 别毕洲 向伟楚 秦尚振 马廉亭.MRI与Dyna-CTA融合影像结合神经导航在经鼻蝶垂体腺瘤切除术中的应用[J].中国临床神经外科杂志,2015,(09):513.[doi:10.13798/j.issn.1009-153X.2015.09.001]
QIN Han,HU Jun-ming,QIN Hai-lin,et al.Application of MRI and CTA fusion images combined with neuronavigation to transsphenoidal microsurgery for pituitary adenomas[J].,2015,(01):513.[doi:10.13798/j.issn.1009-153X.2015.09.001]